COVID-19 Vaccine
At this time, the federal government is giving Maryland approximately 14,000 doses per day for over 2 million people who are eligible. SUPPLY IS VERY LIMITED, especially as the vaccine is becoming available to more people. PLEASE BE PATIENT as the available supply of the vaccine in Maryland works to catch up to the demand. The vaccine will eventually be available to all Marylanders.
Maryland COVID-19 vaccine priority groups
Maryland will distribute the vaccines to five different priority groups based on relative risk of exposure or developing serious illness.
Vaccine prioritization may be subject to change. The state has adopted a rolling vaccine allocation model, meaning it may not wait for every member of a particular group to get vaccinated before moving ahead; individuals will still have the opportunity to be vaccinated in subsequent phases.
WE ARE IN PHASE 1C
Currently Eligible Groups
- All licensed, registered and certified health care providers
- Front line hospital staff
- Nursing home residents and staff
- Individuals with intellectual and developmental disabilities
- Assisted living, independent living, behavioral health and developmentally disabled group homes, and other congregate facilities
- Law enforcement and firefighters, EMS
- Education staff, including K-12 teachers, support staff and daycare providers
- Correctional health care staff and officers
- Public safety workers not covered in Phase 1A
- Health care workers not covered in Phase 1A, including but not limited to lab services, public health, vaccine manufacturing and other health care professions
- Front line judiciary staff
- Continuity of government
- Food/agriculture production, critical manufacturing, U.S. Postal Service, public mass transit, grocery store employees
- Veterinarians and support staff
- Clergy and other essential support for houses of worship
- Adults age 65 and older
- Individuals who are currently receiving hospital-based treatment, including in hospital outpatient centers, AND diagnosed with at least one of the following conditions:
- Cancer patients who are currently in active treatment
- End stage renal disease patients requiring hemodialysis
- Chronic Obstructive Pulmonary Disease (COPD)
- Solid organ transplant recipients
- Sickle cell disease patients
- Diabetic patients (Type 1 and Type 2)
Individuals who are diagnosed with these medical conditions but are not currently receiving hospital-based treatment, including in hospital outpatient centers, will be eligible to receive the vaccine in Maryland’s Phase 2 COVID-19 vaccine distribution.
Phase 1A
Health care workers
Residents and staff of nursing homes
First responders, public safety, corrections
Phase 1B
Individuals with intellectual and developmental disabilities
Assisted living, independent living, behavioral health and developmentally disabled group homes, and other congregate facilities
Adults age 75 and older
Education and continuity of government
Phase 1C
Adults age 65-74
Essential workers in lab services, agriculture, manufacturing, postal service, etc
*Maryland is currently in this stage
Phase 2
Adults 16-64 at increased risk of severe COVID-19 illness due to comorbidities
Essential workers in critical utilities, transportation, food service, etc
Phase 2 will begin after the majority of the Phase 1 has been vaccinated or the federal government’s allocation of vaccines increase.
Phase 3
General population, including healthy adults age 16-64
Phase 3 will begin once the majority of Phase 2 has been vaccinated and/or the federal government’s allocation of vaccines to the state increase.
What are the vaccines?
| Vaccines | Status | Dosing | Efficacy | Potential Side Effects |
|---|---|---|---|---|
| Pfizer | Vaccine has been authorized for emergency use | Two doses, delivered three weeks apart | 95% effective at preventing serious illness | Injection-site pain, fatigue, headaches, chills |
| Moderna | Vaccine has been authorized for emergency use | Two doses, delivered four weeks apart | 94.1% effective at preventing serious illness | Injection-site pain, fatigue, muscle aches, joint pain, headaches, chills |
| Johnson & Johnson | Vaccine has been authorized for emergency use | One Dose | 85% effective at preventing severe illness | Injection site pain, fatigue, headache, muscle pain, joint pain |
| Novavax | Vaccine trials are ongoing | Two doses, delivered three weeks apart | – | Injection site pain, rash, headaches, muscle pain, fever |
| AstraZeneca | Vaccine trials are ongoing | Two doses, delivered four weeks apart | – | Fever, muscle aches, headaches, injection site pain |
Why should you get the vaccine?
Protective
The vaccines provide protection from serious COVID-19 illness.
Promising results
Early clinical trials show the vaccines are highly effective in preventing serious illness.
Pandemic-ending
The vaccines are the best path forward to ending the pandemic.
Minimal side effects
Most of the participants in clinical trials had minimal side effects. The most common were soreness at injection site, fever, or body aches.
Keep On, Maryland
As we proceed with vaccinating the public, we all must keep on slowing the spread of COVID-19.
Keep on wearing your mask, watching your distance and washing your hands. You should get tested and quarantine if you expect exposure or show symptoms.
Resources about the COVID vaccine
The resources on this page will evolve as the Maryland vaccination effort moves forward.
Please check back regularly for information and updates.
Maryland GoVAX COVID-19 Vaccination Support Center
Maryland’s Phased COVID-19 Vaccine Distribution
Maryland COVID-19 Mass Vaccination Site – Six Flags
Allocation to Arms – Vaccine Distribution Timeline for Providers
Maryland COVID-19 Vaccine Fact Sheet – English
Maryland COVID-19 Vaccine Fact Sheet – Spanish
Maryland COVID-19 Vaccine Fact Sheet – Simplified Chinese
Maryland COVID-19 Vaccine Fact Sheet – Traditional Chinese
Maryland COVID-19 Vaccine Fact Sheet – French (AF)
Maryland COVID-19 Vaccine Fact Sheet – Creole
Maryland COVID-19 Vaccine Fact Sheet – Korean
About the Vaccines – English
About the Vaccines – Spanish
About the Vaccines – Simplified Chinese
About the Vaccines – Traditional Chinese
About the Vaccines – French (AF)
About the Vaccines – Creole
About the Vaccines – Korean
COVID-19 Clinical Trials Fact Sheet – English
COVID-19 Clinical Trials Fact Sheet – Spanish
COVID-19 Clinical Trials Fact Sheet – Simplified Chinese
COVID-19 Clinical Trials Fact Sheet – Traditional Chinese
COVID-19 Clinical Trials Fact Sheet – French (AF)
COVID-19 Clinical Trials Fact Sheet – Creole
COVID-19 Clinical Trials Fact Sheet – Korean
COVID-19 Vaccine Fact Sheet – Herd Immunity – English
COVID-19 Vaccine Fact Sheet – Herd Immunity – Spanish
COVID-19 Vaccine Fact Sheet – Herd Immunity – Simplified Chinese
COVID-19 Vaccine Fact Sheet – Herd Immunity – Traditional Chinese
COVID-19 Vaccine Fact Sheet – Herd Immunity – French (AF)
COVID-19 Vaccine Fact Sheet – Herd Immunity – Creole
COVID-19 Vaccine Fact Sheet – Herd Immunity – Korean
